Ginkgo Bioworks Holdings, Inc.

Soaring Eagle Acquisition Corp., which traded on Nasdaq under the ticker SRNG and was sponsored by Eagle Equity Partners, completed its business combination with Ginkgo Bioworks in September 2021, forming Ginkgo Bioworks Holdings, Inc., a synthetic biology and biological programming company operating in the life sciences and biotechnology sector. The blank-check vehicle conducted its IPO in 2021, targeting opportunities in the industrial and pharmaceutical biology space. Ginkgo Bioworks Holdings filed an 8-K with the SEC on May 7, 2026, under accession number 0001628280-26-032093, continuing its post-merger public reporting obligations. Sign up at SpacDesk for full filing histories, sponsor profiles, and real-time data across the entire SPAC universe.